LUNG - Pulmonx Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LUNG is currently covered by 5 analysts with an average price target of $5.94. This is a potential upside of $4.43 (293.38%) from yesterday's end of day stock price of $1.51.

Pulmonx Corp's activity chart (see below) currently has 73 price targets and 61 ratings on display. The stock rating distribution of LUNG is 70.59% BUY and 29.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.68% with an average time for these price targets to be met of 32.78 days.

Highest price target for LUNG is $5, Lowest price target is $2.5, average price target is $6.91.

Most recent stock forecast was given by JASON BEDNAR from PIPER SANDLER on 31-Jul-2025. First documented stock forecast 26-Oct-2020.

Currently out of the existing stock ratings of LUNG, 12 are a BUY (70.59%), 5 are a HOLD (29.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$2.5

$0.94 (60.26%)

$9

20 days ago
(31-Jul-2025)

3/15 (20%)

$0.66 (35.87%)

78

Buy

$5

$3.44 (220.51%)

$16

20 days ago
(31-Jul-2025)

2/5 (40%)

$3.16 (171.74%)

24

Hold

$4.15

$2.59 (166.03%)

$7.5

2 months 29 days ago
(22-May-2025)

6/11 (54.55%)

$1.03 (33.01%)

53

Buy

$16

$14.44 (925.64%)

$12

1 years 19 days ago
(01-Aug-2024)

2/9 (22.22%)

$9.51 (146.53%)

36

Buy

$15

$2.04 (15.74%)

$27

2 years 5 months 25 days ago
(27-Feb-2023)

3/5 (60%)

$4.01 (36.49%)

21

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LUNG (Pulmonx Corp) average time for price targets to be met?

On average it took 32.78 days on average for the stock forecasts to be realized with a an average price target met ratio 36.68

Which analyst has the current highest performing score on LUNG (Pulmonx Corp) with a proven track record?

JASON BEDNAR

Which analyst has the current lower performing score on LUNG (Pulmonx Corp) with a proven track record?

TRAVIS STEED

Which analyst has the most public recommendations on LUNG (Pulmonx Corp)?

Jason Bednar works at PIPER SANDLER and has 34 price targets and 21 ratings on LUNG

Which analyst is the currently most bullish on LUNG (Pulmonx Corp)?

Bob Hopkins with highest potential upside - $61.67

Which analyst is the currently most reserved on LUNG (Pulmonx Corp)?

Travis Steed with lowest potential downside - -$0

Pulmonx Corp in the News

Pulmonx slumps as Piper Sandler downgrades despite Q2 beat

[USA Recession and Crashing Economy Concept] mphillips007 Pulmonx (NASDAQ:LUNG [https://seekingalpha.com/symbol/LUNG]) shares plunged ~41% on Thursday after the lung device maker, with its second-quarter financials, lowered its full-year revenue outlook, prompting Piper Sandler to downgrade the company to Neutral from Overweight. The Redwood City, California-based MedTech posted a double beat with its Q2 results on Wednesday...

Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns

Investing.com – Piper Sandler downgraded Pulmonx Corp . (NASDAQ:LUNG) from Overweight to Neutral on Thursday, while significantly reducing its price target to $2.50 from $9.00 following the company’s second-quarter report. The stock, which has declined over 53% year-to-date, is currently trading at $3.15. According to InvestingPro analysis, the company appears undervalued at current levels. The...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?